| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/2005 | EP1303512B1 Process for preparing arylacetylaminothiazoles |
| 07/20/2005 | EP1299348A4 Compounds and compositions for delivering active agents |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1284959B1 Compounds for modulating the rage receptor |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1268396B1 Diphenyl ether compounds useful in therapy |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1241254B1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 07/20/2005 | EP1221982B1 Isoalloxazine derivatives to neutralize biological contaminants |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | EP1175402B1 Piperidine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1175401B1 Piperazine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1173408B1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes |
| 07/20/2005 | EP1153931B1 Shortened-chain polynucleotides and process for the preparation thereof |
| 07/20/2005 | EP1152757B1 Mmp inhibitors in connective tissue softening |
| 07/20/2005 | EP1146867B1 Antibacterial hydroxamic acid derivatives |
| 07/20/2005 | EP1131113B1 Bioactive prostheses of a conductive material coated with a polymer and a substance with immunosuppressive, antistenotic and antithrombotic properties |
| 07/20/2005 | EP1129077B9 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 07/20/2005 | EP1011648B2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 07/20/2005 | EP1001759B1 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 07/20/2005 | EP0901372B1 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
| 07/20/2005 | EP0869814B1 Stabilisers for live vaccines |
| 07/20/2005 | EP0861085B1 Anti-viral isolates obtained from leeches |
| 07/20/2005 | EP0828851B1 Tripeptidylpeptidase inhibitors |
| 07/20/2005 | EP0814795B1 Topical use of betulinic acid for the treatment of malignant melanoma |
| 07/20/2005 | EP0784430B1 Method for reducing unwanted cellular adhesions |
| 07/20/2005 | CN1643382A A cytocapacity test |
| 07/20/2005 | CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system |
| 07/20/2005 | CN1642974A Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C) |
| 07/20/2005 | CN1642973A A method for treating allergies |
| 07/20/2005 | CN1642970A Process for producing triterpene derivative |
| 07/20/2005 | CN1642968A A human ribonucleotide reductase M2 subunit |
| 07/20/2005 | CN1642966A Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
| 07/20/2005 | CN1642965A Crystals of glucopyranosyloxybenzyl benzene derivative |
| 07/20/2005 | CN1642961A Aminomethyl-substituted thiazolobenzimidazole derivative |
| 07/20/2005 | CN1642960A Substituted amino isoxazoline derivatives and their use as anti-depressants |
| 07/20/2005 | CN1642959A Novel dithiolopyrrolones with therapeutic activity |
| 07/20/2005 | CN1642958A Crystalline polymorphic form of irinotecan hydrochloride |
| 07/20/2005 | CN1642956A Dipyridodiazepinones as reverse transcriptase inhibitors |
| 07/20/2005 | CN1642955A Novel alkoxypyridine-derivatives |
| 07/20/2005 | CN1642954A Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 07/20/2005 | CN1642952A Micronized crystalline tiotropium bromide |
| 07/20/2005 | CN1642951A Heterocyclic tripeptides as hepatitis c inhibitors |
| 07/20/2005 | CN1642950A 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same |
| 07/20/2005 | CN1642949A Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642945A Stable hydrate of a muscarinic receptor antagonist |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642943A Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
| 07/20/2005 | CN1642939A Pyridinoylpiperidines as 5-HTLF agonists |
| 07/20/2005 | CN1642938A New compounds |
| 07/20/2005 | CN1642934A Production of delta9 tetrahydrocannabinol |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642929A Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 07/20/2005 | CN1642927A Cyclic amides |
| 07/20/2005 | CN1642926A Crystalline parecoxib sodium |
| 07/20/2005 | CN1642924A Anxiolytic agents with reduced sedative and ataxic effects |
| 07/20/2005 | CN1642922A Substituted indazoles with anti-cancer activity |
| 07/20/2005 | CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine |
| 07/20/2005 | CN1642917A Non-peptide GnRH antagonists |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642914A Certain 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor XA |
| 07/20/2005 | CN1642913A Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5) |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642911A Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 07/20/2005 | CN1642910A Synthesis of indole thiazole compounds as ligands for the AH receptor |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642906A Novel arylamidine derivative or salt thereof |
| 07/20/2005 | CN1642904A Salts of nateglinide |
| 07/20/2005 | CN1642902A Polyamine compounds and compositions for use in conjunction with cancer therapy |
| 07/20/2005 | CN1642890A Benzyl alcohol derivatives |
| 07/20/2005 | CN1642600A 1, 2-dihydropyrazol-3-ones which controls inflammatory cytokines |
| 07/20/2005 | CN1642599A ACC inhibitors |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1642577A Preparation comprising buprenorphine |
| 07/20/2005 | CN1642576A Absorption enhancing agent |
| 07/20/2005 | CN1642574A Remedies for glomerular diseases |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642572A Remedy for glioblastoma |
| 07/20/2005 | CN1642570A Stable pharmaceutical composition containing factor viii |
| 07/20/2005 | CN1642564A Composition containing moutan root bark extract as active ingredient |
| 07/20/2005 | CN1642560A Hyaluronic acid mediated adenoviral transduction |
| 07/20/2005 | CN1642559A Combination comprising an HMG-CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 07/20/2005 | CN1642558A Theraputic methods and uses of sapogenins and their derivatives |
| 07/20/2005 | CN1642557A Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 07/20/2005 | CN1642556A Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 07/20/2005 | CN1642555A Statin therapy for enhancing cognitive maintenance |
| 07/20/2005 | CN1642554A Benzenesulphonate salt of a morpholine urea derivative for use as a CCR-3 antagonist in the treatment of inflammatory conditions |
| 07/20/2005 | CN1642553A N-{'(2S) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as CCR3 antagonist for the treatment of inflammatory conditions |
| 07/20/2005 | CN1642552A 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642550A Beta-sheet mimetics and composition and methods relating thereto |
| 07/20/2005 | CN1642549A Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo'1, 5-bipyridazine in nanoparticulate form |
| 07/20/2005 | CN1642548A Pharmaceutical composition with combined active agents and methods for using the same |
| 07/20/2005 | CN1642547A Pharmaceutical composition and method for treating disorders of the central nervous system |
| 07/20/2005 | CN1642546A Solid preparation containing single crystal form |
| 07/20/2005 | CN1642544A Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors |
| 07/20/2005 | CN1642543A Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |